Work

TTP399: an investigational liver-selective glucokinase (GK) activator as a potential treatment for type 2 diabetes

Year: 2019

Type: article

Source: Expert Opinion on Investigational Drugs

DOI: 10.1080/13543784.2019.1654993

Authors: Aoife Egan, Adrian Vella

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2968026416

FWCI: 1.73

Cites: 49

Cited by: 23

Related to: 10